AVITA Medical to Present at Upcoming Investor Conferences
February 18, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical Reports Full Second Quarter 2021 Financial Results
February 11, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 11, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and...
AVITA Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 03, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical to Announce Fiscal Second Quarter 2021 Financial Results
January 28, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Jan. 28, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical Announces Preliminary Fiscal Second Quarter 2021 Results
January 12, 2021 08:00 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Jan. 12, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference
December 28, 2020 17:00 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences
December 15, 2020 08:00 ET
|
AVITA Medical
Abstracts Highlighting Clinical and Health Economic Data Reinforce Effectiveness of Treatment with RECELL System More than 10,000 Patients treated with RECELL System globally VALENCIA, Calif. and...
AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer
December 01, 2020 08:00 ET
|
AVITA Medical
VALENCIA, Calif, and MELBOURNE, Australia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing...
AVITA Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 18, 2020 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
AVITA Therapeutics Reports First Quarter 2021 Financial Results
November 10, 2020 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...